We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Castle Biosciences
CSTL
$742M
| $4.62M | 0.01% |
212,036
+114,104
| +117% | +$2.54M |
|
|
VMCAW
1002
CALL
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
| $4.61M | 0.01% |
402,976
| – | – |
|
1003
Colgate-Palmolive
CL
$74.8B
| $4.6M | 0.01% |
47,443
-275,591
| -85% | -$25.4M |
|
1004
Casey's General Stores
CASY
$32.1B
| $4.6M | 0.01% |
12,065
+6,408
| +113% | +$2.14M |
|
|
JBTM
1005
JBT Marel
JBTM
$7.35B
| $4.6M | 0.01% |
48,425
+24,793
| +105% | +$2.34M |
|
1006
Novavax
NVAX
$1.21B
| $4.59M | 0.01% |
+362,690
| New | +$3.65M |
|
1007
Chefs' Warehouse
CHEF
$4.31B
| $4.59M | 0.01% |
117,321
-109,347
| -48% | -$4.04M |
|
1008
Sphere Entertainment
SPHR
$5.02B
| $4.59M | 0.01% |
130,807
+101,682
| +349% | +$3.96M |
|
|
RNAM
1009
DELISTED
Avidity Biosciences
RNAM
| $4.57M | 0.01% |
111,770
+9,906
| +10% | +$284K |
|
1010
Wolfspeed
WOLF
$1.04B
| $4.55M | 0.01% |
200,112
+72,212
| +56% | +$1.87M |
|
1011
CALL
TSMC
TSM
$1.94T
| $4.55M | 0.01% |
26,200
-60,700
| -70% | -$9.21M |
|
1012
Domino's
DPZ
$11.9B
| $4.55M | 0.01% |
+8,819
| New | +$4.5M |
|
1013
FIGS
FIGS
$1.76B
| $4.55M | 0.01% |
853,571
-1,852,585
| -68% | -$9.47M |
|
|
EVE.WS
1014
CALL
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
| $4.54M | 0.01% |
408,848
| – | – |
|
1015
American Healthcare REIT
AHR
$11.1B
| $4.54M | 0.01% |
310,677
-233,479
| -43% | -$3.3M |
|
1016
Rezolute
RZLT
$453M
| $4.5M | 0.01% |
+1,047,230
| New | +$3.6M |
|
1017
Applied Optoelectronics
AAOI
$6.14B
| $4.49M | 0.01% |
541,787
+183,260
| +51% | +$2.01M |
|
1018
Enliven Therapeutics
ELVN
$3.78B
| $4.49M | 0.01% |
+192,100
| New | +$4.04M |
|
1019
Diageo
DEO
$49.6B
| $4.49M | 0.01% |
35,586
+3,386
| +11% | +$466K |
|
1020
Atmus Filtration Technologies
ATMU
$4.12B
| $4.47M | 0.01% |
155,474
-466,901
| -75% | -$14.2M |
|
1021
Under Armour
UAA
$3.01B
| $4.46M | 0.01% |
668,161
-1,251,972
| -65% | -$8.54M |
|
1022
AMC Global Media
AMCX
$450M
| $4.46M | 0.01% |
+461,266
| New | +$6.08M |
|
1023
Zillow
Z
$7.78B
| $4.45M | 0.01% |
95,880
-240,678
| -72% | -$10.6M |
|
|
OSG
1024
Octave Specialty Group
OSG
$257M
| $4.43M | 0.01% |
345,715
+276,210
| +397% | +$4.21M |
|
1025
Universal Insurance Holdings
UVE
$1.26B
| $4.42M | 0.01% |
235,801
+4,140
| +2% | +$80.5K |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.